-
Commercial tissue repositories looking for sources of human tissue, and hospitals that discard tissue from surgeries daily, could appear to be a match made in heaven.
-
When an IRB is confronted with reviewing an unfamiliar commercial collaboration to collect human tissue, it doesn't have to work in a vacuum.
-
As studies become geared toward narrow research questions, targeting specific groups, IRB members will have an even more challenging time resolving ethical dilemmas and weighing risks and benefits.
-
Media attention on research conflicts of interest has made it imperative that IRBs be aware of a wider variety of potential conflicts of interest than what they may have considered in the past, experts say.
-
It's an accepted truism among many in biomedical research: Blacks won't participate at the same rates as other ethnic groups, because of fear of being exploited, thanks to the legacy of the infamous Tuskegee Syphilis Study.
-
IRB members and researchers are beginning to hear more about a new model for weighing risks and benefits in human subjects research. Called component analysis, it requires IRBs to weigh individual procedure risks and benefits against themselves.
-
One of the drawbacks for research conducted in this age of checklists and strong regulatory oversight is that IRBs and research institutions do what they're required to do and sometimes neglect to address the bigger picture, an ethics expert says.
-
One of the bigger headaches for IRBs is having to sift through hundreds or thousands of unanticipated problems submissions when most of these should never have been reported.
-
Intermountain Health Care Urban South Region of Provo, UT, revamped its IRB process with a goal of reducing its lengthy response time and to improve quality in IRB submissions.
-
Public health researchers studying sensitive issues suicide, domestic violence, drug use sometimes find themselves dealing with more than just the survey questions at hand.
